Prostate cancer: Screening “modestly” reduces deaths, Cochrane review concludes
Screening with a PSA (prostate specific antigen) blood test reduces prostate cancer deaths by two for every 1000 men screened, though the risk of overdiagnosis remains high, an updated Cochrane review says.1 The evidence of a “modest” benefit is a shift …